Case number: 1:24-bk-10155 - Adamis Pharmaceuticals Corporation - Delaware Bankruptcy Court

Case Information
  • Case title

    Adamis Pharmaceuticals Corporation

  • Court

    Delaware (debke)

  • Chapter

    11

  • Judge

    Mary F. Walrath

  • Filed

    02/02/2024

  • Last Filing

    03/28/2025

  • Asset

    Yes

  • Vol

    v

Docket Header
JNTADMN



U.S. Bankruptcy Court
District of Delaware (Delaware)
Bankruptcy Petition #: 24-10155-MFW

Assigned to: Mary F. Walrath
Chapter 11
Voluntary
Asset


Date filed:  02/02/2024

Debtor

Adamis Pharmaceuticals Corporation

50 Division Street
Suite 501
Somerville, NJ 08876
SOMERSET-NJ
Tax ID / EIN: 92-2359663
fka
Aardvark Merger Sub, Inc.

fka
DMK Pharmaceuticals Corporation
represented by
Michael G. Busenkell

Gellert Scali Busenkell & Brown, LLC
1201 North Orange Street
3rd Floor
Wilmington, DE 19801
302.425.5812
Fax : 302.425.5814
Email: mbusenkell@gsbblaw.com

U.S. Trustee

U.S. Trustee

Office of the United States Trustee
J. Caleb Boggs Federal Building
844 King Street, Suite 2207
Lockbox 35
Wilmington, DE 19801
(302)-573-6491
 
 

Latest Dockets

Date Filed#Docket Text
03/01/20246Schedules/Statements filed: Sch A-B, Sch D, Sch E-F, Sch G, Sch H, , Decl Concerning Debtors Schs, Stmt of Financial Affairs, 20 Largest Unsecured Creditors,. Filed by Adamis Pharmaceuticals Corporation. (Busenkell, Michael) (Entered: 03/01/2024)
02/06/20245Order Authorizing Joint Administration of Related Chapter 11 Cases. An order has been entered in this case consolidating this case with the case of DMK Pharmaceuticals Corporation, 24-10153 (MFW), for procedural purposes only and providing for its joint administration in accordance with the terms thereof. The docket in Case No. 24-10153 (MFW) should be consulted for all matters affecting this case. Signed on 2/6/2024 (CAF) Modified on 2/7/2024 (LAM). (Entered: 02/06/2024)
02/03/2024Judge Mary F. Walrath added to case (SH) (Entered: 02/03/2024)
02/02/20244Notice of Appearance. Filed by BMC Group, Inc.. (Ordaz, Steven) (Entered: 02/02/2024)
02/02/20243Motion for Joint Administration Filed by Adamis Corporation, Adamis Pharmaceuticals Corporation, Biosyn, Inc., DMK Pharmaceuticals Corporation, Rhombus Pharmaceuticals Corporation. (Busenkell, Michael) (Entered: 02/02/2024)
02/02/20242Receipt of filing fee for Voluntary Petition (Chapter 11)( 24-10155) [misc,volp11a] (1738.00). Receipt Number A11442862, amount $1738.00. (U.S. Treasury) (Entered: 02/02/2024)
02/02/20241Chapter 11 Voluntary Petition . Fee Amount $1738. Filed by Adamis Pharmaceuticals Corporation. (Busenkell, Michael) (Entered: 02/02/2024)